Author: Ken Dropiewski

IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025

Radiology by Comments are Disabled

WINTER SPRINGS, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), today announced it has been ranked 24th on Forbes’ list of America’s Most Successful Small-Cap Companies 2025. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures.

Continue Reading →

Lindus Health Releases “All-in-One Cardiovascular CRO” Offering for Clinical Trials Serving Cardiovascular Health

Coronary/Structural Heart by Comments are Disabled

NEW YORK, Dec. 10, 2024 /PRNewswire/ — Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has launched their “all-in-one” contract research organization (CRO), site, and technology offering bespoke to the unique needs of…

Continue Reading →

Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care

Coronary/Structural Heart by Comments are Disabled

– Collaboration combines Terumo’s ePRISM™ precision medicine software platform with Medis’ QFR® technology – SOMERSET, N.J., Dec. 10, 2024 /PRNewswire/ — Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging…

Continue Reading →

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

Financial by 0 comments

BRISBANE, Australia & EAGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Global Corp. (“ATGC”) today announced that it has launched the roadshow for its proposed initial public offering of 14,800,000 shares of its common stock (“Common Stock”) in the U.S. (the “Offering”). All shares of Common Stock to be sold in the Offering will […]

Continue Reading →

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

Peripheral/Endo by Comments are Disabled

Study represents a significant step forward in Company’s mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solutions Study represents a significant step forward in Company’s mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solutions

Continue Reading →

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Financial by 0 comments

December 04, 2024 06:00 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its […]

Continue Reading →
1 … 196 197 198 199 200 … 1,345